Nanog
From Proteopedia
Line 5: | Line 5: | ||
== Function == | == Function == | ||
- | The expression of Nanog is detectable at embryonic | + | The expression of Nanog is detectable at embryonic stem cells during early stages of the embryo development. It is expressed in the proximal epiblast in a region presumed to be the primitive streak, its expression extends distally as the streak elongates during gastrulation and remains restricted to epiblast. Nanog is vital to maintain pluripotency, it is very much needed, since nanog-deficient inner cell mass from the blastocyst could not generate epiblast and only produce parietal endoderm-like cells. Meanwhile, Nanog-deficient embryonic stem cells lost pluripotency and differentiated into extraembryonic endoderm lineage. [5] |
+ | Nanog expression is closely correlated with self-renewal capability and cell growth of embryonic stem cells. It´s function as a transcription factor have to be inserted into a large network of pluripontency factors that together grant the cells a indifferentiated and pluripotent state. | ||
+ | Nanog expression is inhibits differentiation, thus Nanog expression is rapidly supressed during differentiation, and studies found that a lot of important pathways involved in animal development, such as the Wnt Pathway, have negative regulators of Nanog. [10] | ||
Line 20: | Line 22: | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
- | + | 1. Allouba, M. H., ElGuindy, A. M., Krishnamoorthy, N., Yacoub, M. H., & Aguib, Y. E. (2015). NaNog: A pluripotency homeobox (master) molecule. Global Cardiology Science and Practice, 2015(3), 36.doi:10.5339/gcsp.2015.36 | |
+ | 2. Jauch, R. et al. Crystal Structure and DNA Binding of the Homeodomain of the Stem Cell Transcription Factor Nanog. J. Mol. Biol. (2008) 376, 758–770, doi:10.1016/j.jmb.2007.11.091 | ||
+ | 3. https://www.uniprot.org/uniprot/Q9H9S0 | ||
+ | 4. Gawlik-Rzemieniewska, N., & Bednarek, I. (2015). The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biology & Therapy, 17(1), 1–10.doi:10.1080/15384047.2015.1121348 | ||
+ | 5. Zhang, W., Sui, Y., Ni, J., & Yang, T. (2016). Insights into the Nanog gene: A propeller for stemness in primitive stem cells. International Journal of Biological Sciences, 12(11), 1372–1381.doi:10.7150/ijbs.16349 | ||
+ | 6. Sun C, Sun L, Jiang K, et al. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. The international journal of biochemistry & cell biology. 2013; 45:1099–1108. [PubMed: 23474366] | ||
+ | 7. Chiou SH, Wang ML, Chou YT, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymaltransdifferentiation. Cancer Res. 2010; 70:10433–10444. [PubMed: 21159654]. | ||
+ | 8. Jeter CR, Liu B, Liu X, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011; 30:3833–3845. [PubMed: 21499299] | ||
+ | 9. Liu, Anfei, Xiya Yu, and Shanrong Liu. "Pluripotency transcription factors and cancer stem cells: small genes make a big difference." Chinese journal of cancer 32.9 (2013): 483. | ||
+ | 10.Pan, Guangjin, and James A. Thomson. "Nanog and transcriptional networks in embryonic stem cell pluripotency." Cell research 17.1 (2007): 42. |
Revision as of 20:36, 12 June 2019
Nanog (Human homeobox protein)
|
References
1. Allouba, M. H., ElGuindy, A. M., Krishnamoorthy, N., Yacoub, M. H., & Aguib, Y. E. (2015). NaNog: A pluripotency homeobox (master) molecule. Global Cardiology Science and Practice, 2015(3), 36.doi:10.5339/gcsp.2015.36 2. Jauch, R. et al. Crystal Structure and DNA Binding of the Homeodomain of the Stem Cell Transcription Factor Nanog. J. Mol. Biol. (2008) 376, 758–770, doi:10.1016/j.jmb.2007.11.091 3. https://www.uniprot.org/uniprot/Q9H9S0 4. Gawlik-Rzemieniewska, N., & Bednarek, I. (2015). The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biology & Therapy, 17(1), 1–10.doi:10.1080/15384047.2015.1121348 5. Zhang, W., Sui, Y., Ni, J., & Yang, T. (2016). Insights into the Nanog gene: A propeller for stemness in primitive stem cells. International Journal of Biological Sciences, 12(11), 1372–1381.doi:10.7150/ijbs.16349 6. Sun C, Sun L, Jiang K, et al. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. The international journal of biochemistry & cell biology. 2013; 45:1099–1108. [PubMed: 23474366] 7. Chiou SH, Wang ML, Chou YT, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymaltransdifferentiation. Cancer Res. 2010; 70:10433–10444. [PubMed: 21159654]. 8. Jeter CR, Liu B, Liu X, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011; 30:3833–3845. [PubMed: 21499299] 9. Liu, Anfei, Xiya Yu, and Shanrong Liu. "Pluripotency transcription factors and cancer stem cells: small genes make a big difference." Chinese journal of cancer 32.9 (2013): 483. 10.Pan, Guangjin, and James A. Thomson. "Nanog and transcriptional networks in embryonic stem cell pluripotency." Cell research 17.1 (2007): 42.